Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€13.02

€13.02

-1.290%
-0.17
-1.290%
-

-

 
11.06.21 / Frankfurt WKN: A1J7EB / Name: Nanobiotix / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
-
29.10.20
121.43%
€8.00
29.05.20
61.14%
buy
Your prediction

Nanobiotix Stock

We can see a decrease in the price for Nanobiotix. Compared to yesterday it has lost -€0.170 (-1.290%).
With 1 Sell predictions and 1 Buy predictions the community sentiment towards the Nanobiotix stock is not clear.

Pros and Cons of Nanobiotix in the next few years

Pros
?
Shareholder structure
?
Market Position
?
Conscious of the environment
Cons
?
Growth compared to competition
?
Brand
?
Worthwhile Investment for the next years
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Nanobiotix vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Nanobiotix -1.290% -7.856% 8.410% 48.630% -2.981% 32.384% -30.972%
Quantum Genomics S.A. -0.320% -2.431% 8.578% 32.351% -18.531% - -
Innate Pharma 0.370% 9.473% -4.538% -41.963% -5.527% -37.841% -73.489%
Cellectis Nom. 0.630% 6.560% -3.209% -10.014% -47.318% - -

Other discussions about Nanobiotix Stock

New thread Forum

News

NANOBIOTIX to Host Virtual KOL Event Discussing Potential First-in-Class Radioenhancer NBTXR3 In Immunotherapy on June 11, 2021: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
NANOBIOTIX to Host Virtual KOL Event Discussing Potential First-in-Class Radioenhancer NBTXR3 In Immunotherapy on June 11, 2021


Regulatory News:



NANOBIOTIX (Paris:NANO) (NASDAQ:NBTX) (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to

NANOBIOTIX Announces the Appointment of Bart Van Rhijn as Chief Financial Officer and Member of the Executive Board to Support Global Expansion: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
NANOBIOTIX Announces the Appointment of Bart Van Rhijn as Chief Financial Officer and Member of the Executive Board to Support Global Expansion


Regulatory News:



NANOBIOTIX (Euronext : NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities

NANOBIOTIX to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
NANOBIOTIX to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference


Regulatory News:



NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities